To Evaluate the Efficacy and Safety of Mifepristone in Reducing the Size & amp; Symptoms of Uterine Leiomyoma/Fibroids
ConclusionThis prospective study highlights mifepristone ’s promise as a non-surgical approach to effectively reduce uterine fibroid volume, improve hemoglobin levels, and mitigate uterine blood loss in patients.
Source: The Journal of Obstetrics and Gynecology of India - Category: OBGYN Source Type: research
More News: India Health | Leiomyoma | Men | Menopause | OBGYN | Pain | Pain Management | Study | Ultrasound | Women